Review Article Uncovering the Complexity of Transcriptomes with RNA-Seq

Total Page:16

File Type:pdf, Size:1020Kb

Review Article Uncovering the Complexity of Transcriptomes with RNA-Seq Hindawi Publishing Corporation Journal of Biomedicine and Biotechnology Volume 2010, Article ID 853916, 19 pages doi:10.1155/2010/853916 Review Article Uncovering the Complexity of Transcriptomes with RNA-Seq Valerio Costa,1 Claudia Angelini,2 Italia De Feis,2 and Alfredo Ciccodicola1 1 Institute of Genetics and Biophysics “A. Buzzati-Traverso”, IGB-CNR, 80131 Naples, Italy 2 Istituto per le Applicazioni del Calcolo “Mauro Picone”, IAC-CNR, 80131 Naples, Italy Correspondence should be addressed to Valerio Costa, [email protected] Received 22 February 2010; Accepted 7 April 2010 Academic Editor: Momiao Xiong Copyright © 2010 Valerio Costa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In recent years, the introduction of massively parallel sequencing platforms for Next Generation Sequencing (NGS) protocols, able to simultaneously sequence hundred thousand DNA fragments, dramatically changed the landscape of the genetics studies. RNA-Seq for transcriptome studies, Chip-Seq for DNA-proteins interaction, CNV-Seq for large genome nucleotide variations are only some of the intriguing new applications supported by these innovative platforms. Among them RNA-Seq is perhaps the most complex NGS application. Expression levels of specific genes, differential splicing, allele-specific expression of transcripts can be accurately determined by RNA-Seq experiments to address many biological-related issues. All these attributes are not readily achievable from previously widespread hybridization-based or tag sequence-based approaches. However, the unprecedented level of sensitivity and the large amount of available data produced by NGS platforms provide clear advantages as well as new challenges and issues. This technology brings the great power to make several new biological observations and discoveries, it also requires a considerable effort in the development of new bioinformatics tools to deal with these massive data files. The paper aims to give a survey of the RNA-Seq methodology, particularly focusing on the challenges that this application presents both from a biological and a bioinformatics point of view. 1. Introduction ribosomal RNA (80–90%, rRNA), transfer RNA (5–15%, tRNA), mRNA (2–4%) and a small fraction of intragenic It is commonly known that the genetic information is (i.e., intronic) and intergenic noncoding RNA (1%, ncRNA) conveyed from DNA to proteins via the messenger RNA with undefined regulatory functions [3]. Particularly, both (mRNA) through a finely regulated process. To achieve intragenic and intergenic sequences, enriched in repetitive such a regulation, the concerted action of multiple cis- elements, have long been considered genetically inert, mainly acting proteins that bind to gene flanking regions—“core” composed of “junk” or “selfish” DNA [4]. More recently and “auxiliary” regions—is necessary [1]. In particular, it has been shown that the amount of noncoding DNA core elements, located at the exons’ boundaries, are strictly (ncDNA) increases with organism complexity, ranging from required for initiating the pre-mRNA processing events, 0.25% of prokaryotes’ genome to 98.8% of humans [5]. whereas auxiliary elements, variable in number and location, These observations have strengthened the evidence that are crucial for their ability to enhance or inhibit the basal ncDNA, rather than being junk DNA, is likely to represent splicing activity of a gene. the main driving force accounting for diversity and biological Until recently—less than 10 years ago—the central complexity of living organisms. dogma of genetics indicated with the term “gene” a DNA Since the dawn of genetics, the relationship between portion whose corresponding mRNA encodes a protein. DNA content and biological complexity of living organisms According to this view, RNA was considered a “bridge” in has been a fruitful field of speculation and debate [6]. To the transfer of biological information between DNA and date, several studies, including recent analyses performed proteins, whereas the identity of each expressed gene, and during the ENCODE project, have shown the pervasive of its transcriptional levels, were commonly indicated as nature of eukaryotic transcription with almost the full length “transcriptome” [2]. It was considered to mainly consist of of nonrepeat regions of the genome being transcribed [7]. 2 Journal of Biomedicine and Biotechnology The unexpected level of complexity emerging with the reads in excess of 400 bp. It was followed in 2006 by discovery of endogenous small interfering RNA (siRNA) and the Illumina Genome Analyzer (GA) (http://www.illumina microRNA (miRNA) was only the tip of the iceberg [8]. .com/) capable to generate tens of millions of 32-bp reads. Long interspersed noncoding RNA (lincRNA), promoter- Today, the Illumina GAIIx produces 200 million 75–100 bp and terminator-associated small RNA (PASR and TASR, reads. The last to arrive in the marketplace was the Applied resp.), transcription start site-associated RNA (TSSa-RNA), Biosystems platform based on Sequencing by Oligo Ligation transcription initiation RNA (tiRNA) and many others [8] and Detection (SOLiD) (http://www3.appliedbiosystems represent part of the interspersed and crosslinking pieces .com/AB Home/index.htm), capable of producing 400 mil- of a complicated transcription puzzle. Moreover, to cause lion 50-bp reads, and the Helicos BioScience HeliS- further difficulties, there is the evidence that most of the cope (http://www.helicosbio.com/), the first single-molecule pervasive transcripts identified thus far, have been found sequencer that produces 400 millions 25–35 bp reads. only in specific cell lines (in most of cases in mutant cell lines) While the individual approaches considerably vary in with particular growth conditions, and/or particular tissues. their technical details, the essence of these systems is the In light of this, discovering and interpreting the complexity miniaturization of individual sequencing reactions. Each of of a transcriptome represents a crucial aim for understanding these miniaturized reactions is seeded with DNA molecules, the functional elements of such a genome. Revealing the at limiting dilutions, such that there is a single DNA molecule complexity of the genetic code of living organisms by in each, which is first amplified and then sequenced. To be analyzing the molecular constituents of cells and tissues, will more precise, the genomic DNA is randomly broken into drive towards a more complete knowledge of many biological smaller sizes from which either fragment templates or mate- issues such as the onset of disease and progression. pair templates are created. A common theme among NGS The main goal of the whole transcriptome analyses is technologies is that the template is attached to a solid surface to identify, characterize and catalogue all the transcripts or support (immobilization by primer or template) or indi- expressed within a specific cell/tissue—at a particular stage— rectly immobilized (by linking a polymerase to the support). with the great potential to determine the correct splicing The immobilization of spatially separated templates allows patterns and the structure of genes, and to quantify the simultaneous thousands to billions of sequencing reactions. differential expression of transcripts in both physio- and The physical design of these instruments allows for an pathological conditions [9]. optimal spatial arrangement of each reaction, enabling an In the last 15 years, the development of the hybridiza- efficient readout by laser scanning (or other methods) for tion technology, together with the tag sequence-based millions of individual sequencing reactions onto a standard approaches, allowed to get a first deep insight into this glass slide. While the immense volume of data generated is field, but, beyond a shadow of doubt, the arrival on the attractive, it is arguable that the elimination of the cloning marketplace of the NGS platforms, with all their “Seq” appli- step for the DNA fragments to sequence is the greatest benefit cations, has completely revolutionized the way of thinking of these new technologies. All current methods allow the the molecular biology. direct use of small DNA/RNA fragments not requiring their The aim of this paper is to give an overview of the insertion into a plasmid or other vector, thereby removing RNA-Seq methodology, trying to highlight all the challenges a costly and time-consuming step of traditional Sanger that this application presents from both the biological and sequencing. bioinformatics point of view. It is beyond a shadow of doubt that the arrival of NGS technologies in the marketplace has changed the way we think about scientific approaches in basic, applied and 2. Next Generation Sequencing Technologies clinical research. The broadest application of NGS may be the resequencing of different genomes and in particular, human Since the first complete nucleotide sequence of a gene, pub- genomes to enhance our understanding of how genetic lished in 1964 by Holley [10] and the initial developments differences affect health and disease. Indeed, these platforms of Maxam and Gilbert [11] and Sanger et al. [12] in the have been quickly applied to many genomic contexts giving 1970s (see Figure 1), the world of nucleic acid sequencing rise to the following “Seq” protocols: RNA-Seq for transcrip- was a RNA world and the
Recommended publications
  • Pathogen Receptor Discovery with a Microfluidic Human Membrane Protein Array
    Pathogen receptor discovery with a microfluidic human membrane protein array Yair Glicka,1,Ya’ara Ben-Aria,1, Nir Draymanb, Michal Pellacha, Gregory Neveuc,d, Jim Boonyaratanakornkitc,d, Dorit Avrahamia, Shirit Einavc,d, Ariella Oppenheimb, and Doron Gerbera,2 aMina and Everard Goodman Faculty of Life Sciences, Bar Ilan University, 5290002, Israel; bFaculty of Medicine, Hebrew University, Jerusalem, 9112001, Israel; cDepartment of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA 94305; and dDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305 Edited by Stephen R. Quake, Stanford University, Stanford, CA, and approved March 1, 2016 (received for review September 20, 2015) The discovery of how a pathogen invades a cell requires one to and translate into proteins in situ (10, 11). This approach has determine which host cell receptors are exploited. This determina- enabled the study of the Pseudomonas aeruginosa outer mem- tion is a challenging problem because the receptor is invariably a brane protein for immunity (12). membrane protein, which represents an Achilles heel in proteomics. Combining integrated microfluidics with microarrays and We have developed a universal platform for high-throughput ex- in vitro transcription and translation (TNT) systems may over- – pression and interaction studies of membrane proteins by creating a come all of the above mentioned difficulties (Fig. 1A) (13 16). microfluidic-based comprehensive human membrane protein array The integrated microfluidic device allows smart liquid manage- (MPA). The MPA is, to our knowledge, the first of its kind and offers ment in very low volumes, partitioning, and process integration a powerful alternative to conventional proteomics by enabling the (i.e., protein expression, immobilization, and interaction exper- simultaneous study of 2,100 membrane proteins.
    [Show full text]
  • Function in Vertebrates Receptor-Containing Adaptor
    Evidence for Evolving Toll-IL-1 Receptor-Containing Adaptor Molecule Function in Vertebrates This information is current as Con Sullivan, John H. Postlethwait, Christopher R. Lage, of September 30, 2021. Paul J. Millard and Carol H. Kim J Immunol 2007; 178:4517-4527; ; doi: 10.4049/jimmunol.178.7.4517 http://www.jimmunol.org/content/178/7/4517 Downloaded from References This article cites 60 articles, 30 of which you can access for free at: http://www.jimmunol.org/content/178/7/4517.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 30, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2007 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Evidence for Evolving Toll-IL-1 Receptor-Containing Adaptor Molecule Function in Vertebrates1 Con Sullivan,* John H. Postlethwait,† Christopher R. Lage,* Paul J. Millard,‡ and Carol H. Kim2* In mammals, Toll-IL-1R-containing adaptor molecule 1 (TICAM1)-dependent TLR pathways induce NF-␬B and IFN-␤ re- sponses.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT (51) International Patent Classification: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, C12Q 1/68 (2018.01) A61P 31/18 (2006.01) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, C12Q 1/70 (2006.01) HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (21) International Application Number: MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, PCT/US2018/056167 OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (22) International Filing Date: SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, 16 October 2018 (16. 10.2018) TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (26) Publication Language: English GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (30) Priority Data: UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 62/573,025 16 October 2017 (16. 10.2017) US TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, ΓΕ , IS, IT, LT, LU, LV, (71) Applicant: MASSACHUSETTS INSTITUTE OF MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TECHNOLOGY [US/US]; 77 Massachusetts Avenue, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, Cambridge, Massachusetts 02139 (US).
    [Show full text]
  • The Tumor Suppressor Notch Inhibits Head and Neck Squamous Cell
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 12-2015 THE TUMOR SUPPRESSOR NOTCH INHIBITS HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) TUMOR GROWTH AND PROGRESSION BY MODULATING PROTO-ONCOGENES AXL AND CTNNAL1 (α-CATULIN) Shhyam Moorthy Shhyam Moorthy Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Biochemistry, Biophysics, and Structural Biology Commons, Cancer Biology Commons, Cell Biology Commons, and the Medicine and Health Sciences Commons Recommended Citation Moorthy, Shhyam and Moorthy, Shhyam, "THE TUMOR SUPPRESSOR NOTCH INHIBITS HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) TUMOR GROWTH AND PROGRESSION BY MODULATING PROTO-ONCOGENES AXL AND CTNNAL1 (α-CATULIN)" (2015). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 638. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/638 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. THE TUMOR SUPPRESSOR NOTCH INHIBITS HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) TUMOR GROWTH AND PROGRESSION BY MODULATING PROTO-ONCOGENES AXL AND CTNNAL1 (α-CATULIN) by Shhyam Moorthy, B.S.
    [Show full text]
  • RNA-Seq Transcriptome Reveals Different Molecular Responses
    Zhao et al. BMC Genomics (2020) 21:475 https://doi.org/10.1186/s12864-020-06885-4 RESEARCH ARTICLE Open Access RNA-Seq transcriptome reveals different molecular responses during human and mouse oocyte maturation and fertilization Zheng-Hui Zhao1,2, Tie-Gang Meng1,3, Ang Li1, Heide Schatten4, Zhen-Bo Wang1,2* and Qing-Yuan Sun1,3* Abstract Background: Female infertility is a worldwide concern and the etiology of infertility has not been thoroughly demonstrated. Although the mouse is a good model system to perform functional studies, the differences between mouse and human also need to be considered. The objective of this study is to elucidate the different molecular mechanisms underlying oocyte maturation and fertilization between human and mouse. Results: A comparative transcriptome analysis was performed to identify the differentially expressed genes and associated biological processes between human and mouse oocytes. In total, 8513 common genes, as well as 15, 165 and 6126 uniquely expressed genes were detected in human and mouse MII oocytes, respectively. Additionally, the ratios of non-homologous genes in human and mouse MII oocytes were 37 and 8%, respectively. Functional categorization analysis of the human MII non-homologous genes revealed that cAMP-mediated signaling, sister chromatid cohesin, and cell recognition were the major enriched biological processes. Interestingly, we couldn’t detect any GO categories in mouse non-homologous genes. Conclusions: This study demonstrates that human and mouse oocytes exhibit significant differences in gene expression profiles during oocyte maturation, which probably deciphers the differential molecular responses to oocyte maturation and fertilization. The significant differences between human and mouse oocytes limit the generalizations from mouse to human oocyte maturation.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • Transmembrane Emp24 Domain Proteins in Development and Disease. Cambridge.Org/Grh
    Genetics Research Transmembrane emp24 domain proteins in development and disease. cambridge.org/grh Rachel Aber1,*, Wesley Chan1,* , Sevane Mugisha2 and Loydie A. Jerome-Majewska1,3,4 Review 1Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada; 2Department of *These authors contributed equally to the Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada; 3Department of Human Genetics, preparation of the manuscript McGill University, Montreal, Quebec, Canada and 4Department of Pediatrics, McGill University, Montreal, Quebec, Cite this article: Aber R, Chan W, Mugisha S, Canada Jerome-Majewska LA (2019). Transmembrane emp24 domain proteins in development and Abstract disease.. Genetics Research 101, e14, 1–11. https://doi.org/10.1017/S0016672319000090 Regulated transport through the secretory pathway is essential for embryonic development and homeostasis. Disruptions in this process impact cell fate, differentiation and survival, Received: 24 July 2019 often resulting in abnormalities in morphogenesis and in disease. Several congenital malfor- Revised: 24 October 2019 mations are caused by mutations in genes coding for proteins that regulate cargo protein Accepted: 25 October 2019 transport in the secretory pathway. The severity of mutant phenotypes and the unclear aeti- Keywords: ology of transport protein-associated pathologies have motivated research on the regulation cargo receptor; development; disease; p24; and mechanisms through which these proteins contribute to morphogenesis. This review TMED focuses on the role of the p24/transmembrane emp24 domain (TMED) family of cargo recep- Author for correspondence: tors in development and disease. Dr Loydie A. Jerome-Majewska, E-mail: [email protected] 1. Introduction Nascent proteins are modified and transported to their final destination via the secretory path- way (Figure 1).
    [Show full text]
  • The Genetic Program of Pancreatic Beta-Cell Replication in Vivo
    Page 1 of 65 Diabetes The genetic program of pancreatic beta-cell replication in vivo Agnes Klochendler1, Inbal Caspi2, Noa Corem1, Maya Moran3, Oriel Friedlich1, Sharona Elgavish4, Yuval Nevo4, Aharon Helman1, Benjamin Glaser5, Amir Eden3, Shalev Itzkovitz2, Yuval Dor1,* 1Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel 2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. 3Department of Cell and Developmental Biology, The Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel 4Info-CORE, Bioinformatics Unit of the I-CORE Computation Center, The Hebrew University and Hadassah, The Institute for Medical Research Israel- Canada, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel 5Endocrinology and Metabolism Service, Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel *Correspondence: [email protected] Running title: The genetic program of pancreatic β-cell replication 1 Diabetes Publish Ahead of Print, published online March 18, 2016 Diabetes Page 2 of 65 Abstract The molecular program underlying infrequent replication of pancreatic beta- cells remains largely inaccessible. Using transgenic mice expressing GFP in cycling cells we sorted live, replicating beta-cells and determined their transcriptome. Replicating beta-cells upregulate hundreds of proliferation- related genes, along with many novel putative cell cycle components. Strikingly, genes involved in beta-cell functions, namely glucose sensing and insulin secretion were repressed. Further studies using single molecule RNA in situ hybridization revealed that in fact, replicating beta-cells double the amount of RNA for most genes, but this upregulation excludes genes involved in beta-cell function.
    [Show full text]
  • TMED1 Mouse Monoclonal Antibody [Clone ID: OTI7D2] Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for CF503620 TMED1 Mouse Monoclonal Antibody [Clone ID: OTI7D2] Product data: Product Type: Primary Antibodies Clone Name: OTI7D2 Applications: IF, WB Recommended Dilution: WB 1:500, IF 1:100 Reactivity: Human, Mouse, Rat Host: Mouse Isotype: IgG1 Clonality: Monoclonal Immunogen: Full length human recombinant protein of human TMED1(NP_006849) produced in HEK293T cell. Formulation: Lyophilized powder (original buffer 1X PBS, pH 7.3, 8% trehalose) Reconstitution Method: For reconstitution, we recommend adding 100uL distilled water to a final antibody concentration of about 1 mg/mL. To use this carrier-free antibody for conjugation experiment, we strongly recommend performing another round of desalting process. (OriGene recommends Zeba Spin Desalting Columns, 7KMWCO from Thermo Scientific) Purification: Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) Conjugation: Unconjugated Storage: Store at -20°C as received. Stability: Stable for 12 months from date of receipt. Predicted Protein Size: 22.8 kDa Gene Name: Homo sapiens transmembrane p24 trafficking protein 1 (TMED1), transcript variant 1, mRNA. Database Link: NP_006849 Entrez Gene 17083 MouseEntrez Gene 315461 RatEntrez Gene 11018 Human Q13445 Background: The protein encoded by this gene was identified by its interaction with interleukin 1 receptor- like 1 (IL1RL1). This protein lacks any similarity to other interleukin 1 ligands. The functional significance of its interaction with IL1RL1 is not known. [provided by RefSeq, Jul 2008] This product is to be used for laboratory only.
    [Show full text]
  • Human Social Genomics in the Multi-Ethnic Study of Atherosclerosis
    Getting “Under the Skin”: Human Social Genomics in the Multi-Ethnic Study of Atherosclerosis by Kristen Monét Brown A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Epidemiological Science) in the University of Michigan 2017 Doctoral Committee: Professor Ana V. Diez-Roux, Co-Chair, Drexel University Professor Sharon R. Kardia, Co-Chair Professor Bhramar Mukherjee Assistant Professor Belinda Needham Assistant Professor Jennifer A. Smith © Kristen Monét Brown, 2017 [email protected] ORCID iD: 0000-0002-9955-0568 Dedication I dedicate this dissertation to my grandmother, Gertrude Delores Hampton. Nanny, no one wanted to see me become “Dr. Brown” more than you. I know that you are standing over the bannister of heaven smiling and beaming with pride. I love you more than my words could ever fully express. ii Acknowledgements First, I give honor to God, who is the head of my life. Truly, without Him, none of this would be possible. Countless times throughout this doctoral journey I have relied my favorite scripture, “And we know that all things work together for good, to them that love God, to them who are called according to His purpose (Romans 8:28).” Secondly, I acknowledge my parents, James and Marilyn Brown. From an early age, you two instilled in me the value of education and have been my biggest cheerleaders throughout my entire life. I thank you for your unconditional love, encouragement, sacrifices, and support. I would not be here today without you. I truly thank God that out of the all of the people in the world that He could have chosen to be my parents, that He chose the two of you.
    [Show full text]
  • Screening the Mammalian Extracellular Proteome for Regulators of Embryonic Human Stem Cell Pluripotency
    Screening the mammalian extracellular proteome for regulators of embryonic human stem cell pluripotency Rodolfo Gonzaleza,b, Lori L. Jenningsb, Mark Knuthb, Anthony P. Orthb, Heath E. Klockb, Weija Oub, Julie Feuerhelmb, Mitchell V. Hullb, Eric Koesemab, Yuping Wangb, Jia Zhangb, Chunlei Wub, Charles Y. Chob, Andrew I. Sub, Serge Batalovb, Hong Chenc, Kristen Johnsonb,BryanLaffitteb, Deborah G. Nguyenb,EvanY.Snyderd, Peter G. Schultza,b,1, Jennifer L. Harrisb, and Scott A. Lesleyb,e aDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037; bGenomics Institute of the Novartis Research Foundation, San Diego, CA 92121; cNovartis Institute for Biomedical Research, Cambridge, MA 02139; dCenter for Neuroscience and Aging Research, Burnham Institute for Medical Research, La Jolla, CA 92037; and eDepartment of Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037 Contributed by Peter G. Schultz, December 16, 2009 (sent for review October 9, 2009) Approximately 3,500 mammalian genes are predicted to be secreted prioritized from the total mouse and human extracellular pro- or single-pass transmembrane proteins. The function of the majority teome by genome-wide association studies and genetic mapping of these genes is still unknown, and a number of the encoded of quantitative trait loci (QTL) from mouse genetic studies. This proteins might find use as new therapeutic agents themselves or as gene set was expressed in multiple expression vectors to provide targets for small molecule or antibody drug development. To analyze native and Fc-fusion proteins, and it provided 806 proteins for the physiological activities of the extracellular proteome, we devel- use in cell-based phenotypic and reporter screens.
    [Show full text]